• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

渗透药物递送的深入了解。

An insight to osmotic drug delivery.

机构信息

School of Pharmaceutical Sciences, Shoolini University, Bajhol, Solan (H.P.), India.

出版信息

Curr Drug Deliv. 2012 May;9(3):285-96. doi: 10.2174/156720112800389106.

DOI:10.2174/156720112800389106
PMID:22452403
Abstract

In a typical therapeutic regimen the drug dose and the dosing interval are optimized to maintain drug concentration within the therapeutic window, thus ensuring efficacy while minimizing toxic effects. For many decades treatment of acute disease or a chronic illness has been mostly accomplished by delivery of drugs to patients using various pharmaceutical dosage forms. The immediate release conventional dosage form does not provide the proper plasma concentration of drug for prolonged period. This results in the development of various controlled drug delivery system. Among which the osmotic drug delivery systems (ODDS) are gaining importance as these systems deliver the drug at specific time as per the path physiological need of the disease, resulting in improved patient therapeutic efficacy and compliance. They work on the principle of osmotic pressure for controlling the delivery of the drug. Osmotic drug delivery systems with their versatility and their highly predictable drug release rates offer various biomedical advantages when given parenterally like reduced dose, targeting of site, avoiding gastrointestinal stability, hepatic bypass of drug molecule and follows zero order kinetics. Osmosis is an aristocratic phenomenon that seizes the attention for its exploitation in zero-order drug delivery systems. The release of the drug is independent of pH and physiological factors of the GIT to a large extent. Optimizing semi-permeable membrane characteristics and osmotic agent can modulate delivery of drug from the system. This review highlights the theoretical concept of drug delivery, history, types of oral osmotic drug delivery systems, factors affecting the drug delivery system, advantages and disadvantages of this delivery system, theoretical aspects, applications, and the marketed status.

摘要

在典型的治疗方案中,药物剂量和给药间隔时间被优化,以将药物浓度维持在治疗窗口内,从而在最小化毒性作用的同时确保疗效。几十年来,急性疾病或慢性病的治疗主要通过各种药物剂型向患者给药来完成。速释常规剂型不能在长时间内提供适当的药物血浆浓度。这导致了各种控释给药系统的发展。其中,渗透给药系统(ODDS)越来越受到重视,因为这些系统根据疾病的生理需要,在特定时间以特定的方式输送药物,从而提高了患者的治疗效果和依从性。它们基于渗透压原理来控制药物的输送。渗透给药系统具有多功能性和高度可预测的药物释放率,当经肠胃外给药时具有多种生物医学优势,例如减少剂量、靶向给药部位、避免胃肠道稳定性、药物分子的肝旁路和遵循零级动力学。渗透是一种贵族现象,因其在零级药物输送系统中的应用而引起了人们的关注。药物的释放在很大程度上独立于胃肠道的 pH 值和生理因素。优化半渗透膜特性和渗透压剂可以调节药物从系统中的释放。本文综述了药物输送的理论概念、历史、口服渗透药物输送系统的类型、影响药物输送系统的因素、该输送系统的优缺点、理论方面、应用和市场现状。

相似文献

1
An insight to osmotic drug delivery.渗透药物递送的深入了解。
Curr Drug Deliv. 2012 May;9(3):285-96. doi: 10.2174/156720112800389106.
2
Osmotically controlled drug delivery system with associated drugs.渗透压控制药物传递系统及其相关药物。
J Pharm Pharm Sci. 2010;13(4):571-88. doi: 10.18433/j38w25.
3
Pharmaceutical approaches to colon targeted drug delivery systems.结肠靶向给药系统的药物学方法。
J Pharm Pharm Sci. 2003 Jan-Apr;6(1):33-66.
4
Osmotic drug delivery systems: basics and design approaches.
Recent Pat Drug Deliv Formul. 2013 Aug;7(2):150-61. doi: 10.2174/1872211311307020007.
5
An overview of recent patents on oral osmotic drug delivery systems.口腔渗透给药系统近期专利综述。
Recent Pat Drug Deliv Formul. 2007;1(3):236-55. doi: 10.2174/187221107782331638.
6
Formulation aspects in the development of osmotically controlled oral drug delivery systems.渗透控释口服给药系统开发中的制剂方面
J Control Release. 2002 Feb 19;79(1-3):7-27. doi: 10.1016/s0168-3659(01)00550-8.
7
Osmotic drug delivery system as a part of modified release dosage form.渗透给药系统作为缓控释剂型的一部分。
ISRN Pharm. 2012;2012:528079. doi: 10.5402/2012/528079. Epub 2012 Jul 17.
8
Osmotic micropumps for drug delivery.渗透型药物输送微泵。
Adv Drug Deliv Rev. 2012 Nov;64(14):1617-27. doi: 10.1016/j.addr.2012.02.003. Epub 2012 Feb 12.
9
Osmotically controlled oral drug delivery.
Drug Dev Ind Pharm. 2000 Jul;26(7):695-708. doi: 10.1081/ddc-100101287.
10
Recent advances in asymmetric membrane capsule based osmotic pump: a patent overview.基于不对称膜胶囊的渗透泵的最新进展:专利综述
Recent Pat Drug Deliv Formul. 2012 Apr 1;6(1):66-72. doi: 10.2174/187221112799219099.

引用本文的文献

1
Novel Injectable Fluorescent Polymeric Nanocarriers for Intervertebral Disc Application.用于椎间盘应用的新型可注射荧光聚合物纳米载体
J Funct Biomater. 2023 Jan 17;14(2):52. doi: 10.3390/jfb14020052.
2
Osmotic Pump Drug Delivery Systems-A Comprehensive Review.渗透泵给药系统——综述
Pharmaceuticals (Basel). 2022 Nov 18;15(11):1430. doi: 10.3390/ph15111430.
3
Quality by Design (QbD)-Based Numerical and Graphical Optimization Technique for the Development of Osmotic Pump Controlled-Release Metoclopramide HCl Tablets.
基于质量源于设计(QbD)的数值和图形优化技术,开发渗透泵控释盐酸甲氧氯普胺片。
Drug Des Devel Ther. 2020 Nov 26;14:5217-5234. doi: 10.2147/DDDT.S278918. eCollection 2020.
4
Preparation and characterization of metoprolol tartrate containing matrix type transdermal drug delivery system.含酒石酸美托洛尔的基质型透皮给药系统的制备与表征
Drug Deliv Transl Res. 2017 Feb;7(1):66-76. doi: 10.1007/s13346-016-0334-7.
5
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release.可降解控释聚合物与聚合物纳米颗粒:药物释放控制机制
Chem Rev. 2016 Feb 24;116(4):2602-63. doi: 10.1021/acs.chemrev.5b00346. Epub 2016 Feb 8.